Tom Beatty, Sr. Principal UDI Compliance, and Bruce Fieggen, VP of Project Management
FDA's newly passed UDI rule has had a major impact on the medical device industry. Our experts will present on best practices for compliance with the UDI rule, including an easy-to-understand interpretation of the required compliance timelines for each class of device, a review of the individual components that make up the UDI, as well as guidance on the available labeling standards (GS1, HIBCC, ISBT 128). . Ideal participants include medical device quality and compliance executives, I.T. decision makers, and anyone else for whom the Unique Device Identification rule is a concern. The event is being presented by QDevice, the medical device division of QPharma, a leading regulatory compliance consulting firm.